Nasz Lekarz Osrodek Badan Klinicznych

Torun 87-100

0 studies enrolling now · 5 studies all time

What they study most

Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Diffuse Large B-cell Lymphoma, Lymphoma, Plaque Psoriasis, Small Lymphocytic Lymphoma

Studies at this site

• Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL — Running, not enrolling
• A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Running, not enrolling
• Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients — Running, not enrolling
• Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas — Stopped early
• A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis — Completed